在患有类风湿性关节炎和加速结节症的患者的双边自发性肺胸部
Roshini Kurian1, Sajeel Ahmed2, Avinash Aujayeb3
1Internal Medicine, Newcastle Upon Tyne University hospitals, Newcastle, UK.
Breathe (Sheffield, England)
|December 11, 2024
概括
类风湿性关节炎 (RA) 可以导致可能破裂的肺结节,导致肺胸. 这一案例突出了加速RA结节症的复发性肺胸病,这是生物治疗的并发症.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 是一种全身性自身免疫性疾病.
- 呼吸道并发症,包括肺结节和肺胸,是已知的RA的表现.
- 针对RA的生物疗法可以调节免疫反应,可能影响疾病的表现.
研究的目的:
- 报告一个罕见的复发性肺胸病例.
- 调查加速类风湿性关节炎结核病与生物治疗之间的关联.
- 为了突出RA治疗的潜在呼吸道并发症.
主要方法:
- 案例报告的呈现方式.
- 审查患者的病史和治疗过程.
- 分析与RA和肺胸部相关的临床和放射学发现.
主要成果:
- 患者经历了重复出现的肺胸部发作.
- 肺部加速结节症被确定为原因.
- 这种情况是该患者为类风湿性关节炎进行生物治疗的次要原因.
结论:
- 由于加速性类风湿性关节炎结核病,可能会出现复发性肺胸病.
- 生物治疗可能与RA相关的肺结节的发展或恶化有关.
- 在接受生物治疗的RA患者中,密切监测呼吸道并发症至关重要.
相关概念视频
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
Pneumothorax-I
169
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
169
Pleural Effusion I: Introduction
557
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
557
Pleural Effusion II: Symptoms and Management
154
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
154
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K


